Global pharma giant GlaxoSmithKline Pharmaceuticals Ltd received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order issued by the Income Tax Department on Tuesday.
Global healthcare major informed in regulatory filings of an Income Tax Order for Assessment Year 2022-23 issuing income tax refund of Rs 222.23 cr including interest.
GlaxoSmithKline Pharmaceuticals declared a 37.8% year-on-year (YoY) increase in net profit to Rs.182.3 crore in the first quarter ended June 30, 2024. GlaxoSmithKline’s net profit in the same quarter was Rs.132.3 crore while revenue rose by 7% to Rs.814.7 crore from Rs.761.7 crore in the same period last year
'We Would Treat Him Better...': Iceland Cricket Mocks Australia's T20 World Cup Exit Over Bizarre Steve Smith Non-Selection Decision
Will PhonePe IPO Impact Paytm Stock?
Gold, Silver Prices Rebound On MCX, Gold Up 1.24% To ₹1,53,294, Silver Surges 3.81% To ₹2,37,490 Amid Global Macro Factors
'Excitement Just Got Bigger': Akshay Kumar Fans React To Report Of Bhooth Bangla First Song Being Attached To Ranveer Singh's Dhurandhar 2
